Loading…

Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders

Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2022-10, Vol.11 (21), p.6400
Main Authors: Horigian, Viviana E, Schmidt, Renae D, Shmueli-Blumberg, Dikla, Hefner, Kathryn, Feinberg, Judith, Kondapaka, Radhika, Feaster, Daniel J, Duan, Rui, Gonzalez, Sophia, Davis, Carly, Marín-Navarrete, Rodrigo, Tross, Susan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823
cites cdi_FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823
container_end_page
container_issue 21
container_start_page 6400
container_title Journal of clinical medicine
container_volume 11
creator Horigian, Viviana E
Schmidt, Renae D
Shmueli-Blumberg, Dikla
Hefner, Kathryn
Feinberg, Judith
Kondapaka, Radhika
Feaster, Daniel J
Duan, Rui
Gonzalez, Sophia
Davis, Carly
Marín-Navarrete, Rodrigo
Tross, Susan
description Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this research has been limited to single site studies of self-reported outcomes. The current research evaluated suicidality as a predictor of overdose events in 2541 participants who use substances enrolled across eight multi-site clinical trials completed within the National Drug Abuse Treatment Clinical Trials Network between 2012 to 2021. The trials assessed baseline suicidality with the Concise Health Risk Tracking Self-Report (CHRT-SR). Overdose events were determined by reports of adverse events, cause of death, or hospitalization due to substance overdose, and verified through a rigorous adjudication process. Multivariate logistic regression was performed to assess continuous CHRT-SR score as a predictor of overdose, controlling for covariates. CHRT-SR score was associated with overdose events ( = 0.03) during the trial; the likelihood of overdose increased as continuous CHRT score increased (OR 1.02). Participants with lifetime heroin use were more likely to overdose (OR 3.08). Response to the marked rise in overdose deaths should integrate suicide risk reduction as part of prevention strategies.
doi_str_mv 10.3390/jcm11216400
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9657076</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2735873555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823</originalsourceid><addsrcrecordid>eNpdkc1LxDAQxYMo7qKevEvAiyCrk6RN0osgfoOwou45pEmqWdpGk1bxv7fL6rI6MMzA_Hi84SG0T-CEsQJO56YhhBKeAWygMQUhJsAk21zbR2gvpTkMJWVGidhGI8YZp5zKMXp86r3xVte--8I6YY0forPedCHiUOHph4s2JId1E9oX_KA779ou4U_fveKnvkydbo3Ds4G49ClE62LaRVuVrpPb-5k7aHZ99XxxO7mf3txdnN9PTAZFNymFtNyWlSstlU5WOS80q4BbSjIqoCoBSimNlYSwzBgAQZlhuuAmr0otKdtBZ0vdt75snDWDsahr9RZ9o-OXCtqrv5fWv6qX8KEKngsQfBA4-hGI4b13qVONT8bVtW5d6JOiguVy6Dwf0MN_6Dz0sR3eW1AZZyDJgjpeUiaGlKKrVmYIqEVcai2ugT5Y979if8Nh34W4kI0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2734630815</pqid></control><display><type>article</type><title>Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders</title><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Horigian, Viviana E ; Schmidt, Renae D ; Shmueli-Blumberg, Dikla ; Hefner, Kathryn ; Feinberg, Judith ; Kondapaka, Radhika ; Feaster, Daniel J ; Duan, Rui ; Gonzalez, Sophia ; Davis, Carly ; Marín-Navarrete, Rodrigo ; Tross, Susan</creator><creatorcontrib>Horigian, Viviana E ; Schmidt, Renae D ; Shmueli-Blumberg, Dikla ; Hefner, Kathryn ; Feinberg, Judith ; Kondapaka, Radhika ; Feaster, Daniel J ; Duan, Rui ; Gonzalez, Sophia ; Davis, Carly ; Marín-Navarrete, Rodrigo ; Tross, Susan</creatorcontrib><description>Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this research has been limited to single site studies of self-reported outcomes. The current research evaluated suicidality as a predictor of overdose events in 2541 participants who use substances enrolled across eight multi-site clinical trials completed within the National Drug Abuse Treatment Clinical Trials Network between 2012 to 2021. The trials assessed baseline suicidality with the Concise Health Risk Tracking Self-Report (CHRT-SR). Overdose events were determined by reports of adverse events, cause of death, or hospitalization due to substance overdose, and verified through a rigorous adjudication process. Multivariate logistic regression was performed to assess continuous CHRT-SR score as a predictor of overdose, controlling for covariates. CHRT-SR score was associated with overdose events ( = 0.03) during the trial; the likelihood of overdose increased as continuous CHRT score increased (OR 1.02). Participants with lifetime heroin use were more likely to overdose (OR 3.08). Response to the marked rise in overdose deaths should integrate suicide risk reduction as part of prevention strategies.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm11216400</identifier><identifier>PMID: 36362628</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Clinical trials ; Drug abuse ; Drug overdose ; Drug use ; Fatalities ; Heroin ; Hospitalization ; Mental disorders ; Mental health ; Narcotics ; Patients ; Pessimism ; Post traumatic stress disorder ; Respiratory distress syndrome ; Substance abuse treatment ; Substance use disorder ; Suicidal behavior ; Suicides &amp; suicide attempts</subject><ispartof>Journal of clinical medicine, 2022-10, Vol.11 (21), p.6400</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823</citedby><cites>FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823</cites><orcidid>0000-0002-0788-5767 ; 0000-0002-6084-8199 ; 0000-0002-3578-0014 ; 0000-0002-0390-0712 ; 0000-0003-4206-7214 ; 0000-0002-6172-7460</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2734630815/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2734630815?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36362628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Horigian, Viviana E</creatorcontrib><creatorcontrib>Schmidt, Renae D</creatorcontrib><creatorcontrib>Shmueli-Blumberg, Dikla</creatorcontrib><creatorcontrib>Hefner, Kathryn</creatorcontrib><creatorcontrib>Feinberg, Judith</creatorcontrib><creatorcontrib>Kondapaka, Radhika</creatorcontrib><creatorcontrib>Feaster, Daniel J</creatorcontrib><creatorcontrib>Duan, Rui</creatorcontrib><creatorcontrib>Gonzalez, Sophia</creatorcontrib><creatorcontrib>Davis, Carly</creatorcontrib><creatorcontrib>Marín-Navarrete, Rodrigo</creatorcontrib><creatorcontrib>Tross, Susan</creatorcontrib><title>Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this research has been limited to single site studies of self-reported outcomes. The current research evaluated suicidality as a predictor of overdose events in 2541 participants who use substances enrolled across eight multi-site clinical trials completed within the National Drug Abuse Treatment Clinical Trials Network between 2012 to 2021. The trials assessed baseline suicidality with the Concise Health Risk Tracking Self-Report (CHRT-SR). Overdose events were determined by reports of adverse events, cause of death, or hospitalization due to substance overdose, and verified through a rigorous adjudication process. Multivariate logistic regression was performed to assess continuous CHRT-SR score as a predictor of overdose, controlling for covariates. CHRT-SR score was associated with overdose events ( = 0.03) during the trial; the likelihood of overdose increased as continuous CHRT score increased (OR 1.02). Participants with lifetime heroin use were more likely to overdose (OR 3.08). Response to the marked rise in overdose deaths should integrate suicide risk reduction as part of prevention strategies.</description><subject>Clinical trials</subject><subject>Drug abuse</subject><subject>Drug overdose</subject><subject>Drug use</subject><subject>Fatalities</subject><subject>Heroin</subject><subject>Hospitalization</subject><subject>Mental disorders</subject><subject>Mental health</subject><subject>Narcotics</subject><subject>Patients</subject><subject>Pessimism</subject><subject>Post traumatic stress disorder</subject><subject>Respiratory distress syndrome</subject><subject>Substance abuse treatment</subject><subject>Substance use disorder</subject><subject>Suicidal behavior</subject><subject>Suicides &amp; suicide attempts</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkc1LxDAQxYMo7qKevEvAiyCrk6RN0osgfoOwou45pEmqWdpGk1bxv7fL6rI6MMzA_Hi84SG0T-CEsQJO56YhhBKeAWygMQUhJsAk21zbR2gvpTkMJWVGidhGI8YZp5zKMXp86r3xVte--8I6YY0forPedCHiUOHph4s2JId1E9oX_KA779ou4U_fveKnvkydbo3Ds4G49ClE62LaRVuVrpPb-5k7aHZ99XxxO7mf3txdnN9PTAZFNymFtNyWlSstlU5WOS80q4BbSjIqoCoBSimNlYSwzBgAQZlhuuAmr0otKdtBZ0vdt75snDWDsahr9RZ9o-OXCtqrv5fWv6qX8KEKngsQfBA4-hGI4b13qVONT8bVtW5d6JOiguVy6Dwf0MN_6Dz0sR3eW1AZZyDJgjpeUiaGlKKrVmYIqEVcai2ugT5Y979if8Nh34W4kI0</recordid><startdate>20221029</startdate><enddate>20221029</enddate><creator>Horigian, Viviana E</creator><creator>Schmidt, Renae D</creator><creator>Shmueli-Blumberg, Dikla</creator><creator>Hefner, Kathryn</creator><creator>Feinberg, Judith</creator><creator>Kondapaka, Radhika</creator><creator>Feaster, Daniel J</creator><creator>Duan, Rui</creator><creator>Gonzalez, Sophia</creator><creator>Davis, Carly</creator><creator>Marín-Navarrete, Rodrigo</creator><creator>Tross, Susan</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0788-5767</orcidid><orcidid>https://orcid.org/0000-0002-6084-8199</orcidid><orcidid>https://orcid.org/0000-0002-3578-0014</orcidid><orcidid>https://orcid.org/0000-0002-0390-0712</orcidid><orcidid>https://orcid.org/0000-0003-4206-7214</orcidid><orcidid>https://orcid.org/0000-0002-6172-7460</orcidid></search><sort><creationdate>20221029</creationdate><title>Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders</title><author>Horigian, Viviana E ; Schmidt, Renae D ; Shmueli-Blumberg, Dikla ; Hefner, Kathryn ; Feinberg, Judith ; Kondapaka, Radhika ; Feaster, Daniel J ; Duan, Rui ; Gonzalez, Sophia ; Davis, Carly ; Marín-Navarrete, Rodrigo ; Tross, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Clinical trials</topic><topic>Drug abuse</topic><topic>Drug overdose</topic><topic>Drug use</topic><topic>Fatalities</topic><topic>Heroin</topic><topic>Hospitalization</topic><topic>Mental disorders</topic><topic>Mental health</topic><topic>Narcotics</topic><topic>Patients</topic><topic>Pessimism</topic><topic>Post traumatic stress disorder</topic><topic>Respiratory distress syndrome</topic><topic>Substance abuse treatment</topic><topic>Substance use disorder</topic><topic>Suicidal behavior</topic><topic>Suicides &amp; suicide attempts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horigian, Viviana E</creatorcontrib><creatorcontrib>Schmidt, Renae D</creatorcontrib><creatorcontrib>Shmueli-Blumberg, Dikla</creatorcontrib><creatorcontrib>Hefner, Kathryn</creatorcontrib><creatorcontrib>Feinberg, Judith</creatorcontrib><creatorcontrib>Kondapaka, Radhika</creatorcontrib><creatorcontrib>Feaster, Daniel J</creatorcontrib><creatorcontrib>Duan, Rui</creatorcontrib><creatorcontrib>Gonzalez, Sophia</creatorcontrib><creatorcontrib>Davis, Carly</creatorcontrib><creatorcontrib>Marín-Navarrete, Rodrigo</creatorcontrib><creatorcontrib>Tross, Susan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horigian, Viviana E</au><au>Schmidt, Renae D</au><au>Shmueli-Blumberg, Dikla</au><au>Hefner, Kathryn</au><au>Feinberg, Judith</au><au>Kondapaka, Radhika</au><au>Feaster, Daniel J</au><au>Duan, Rui</au><au>Gonzalez, Sophia</au><au>Davis, Carly</au><au>Marín-Navarrete, Rodrigo</au><au>Tross, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2022-10-29</date><risdate>2022</risdate><volume>11</volume><issue>21</issue><spage>6400</spage><pages>6400-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Increasing rates of overdose and overdose deaths are a significant public health problem. Research has examined co-occurring mental health conditions, including suicidality, as a risk factor for intentional and unintentional overdose among individuals with substance use disorder (SUD). However, this research has been limited to single site studies of self-reported outcomes. The current research evaluated suicidality as a predictor of overdose events in 2541 participants who use substances enrolled across eight multi-site clinical trials completed within the National Drug Abuse Treatment Clinical Trials Network between 2012 to 2021. The trials assessed baseline suicidality with the Concise Health Risk Tracking Self-Report (CHRT-SR). Overdose events were determined by reports of adverse events, cause of death, or hospitalization due to substance overdose, and verified through a rigorous adjudication process. Multivariate logistic regression was performed to assess continuous CHRT-SR score as a predictor of overdose, controlling for covariates. CHRT-SR score was associated with overdose events ( = 0.03) during the trial; the likelihood of overdose increased as continuous CHRT score increased (OR 1.02). Participants with lifetime heroin use were more likely to overdose (OR 3.08). Response to the marked rise in overdose deaths should integrate suicide risk reduction as part of prevention strategies.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36362628</pmid><doi>10.3390/jcm11216400</doi><orcidid>https://orcid.org/0000-0002-0788-5767</orcidid><orcidid>https://orcid.org/0000-0002-6084-8199</orcidid><orcidid>https://orcid.org/0000-0002-3578-0014</orcidid><orcidid>https://orcid.org/0000-0002-0390-0712</orcidid><orcidid>https://orcid.org/0000-0003-4206-7214</orcidid><orcidid>https://orcid.org/0000-0002-6172-7460</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2022-10, Vol.11 (21), p.6400
issn 2077-0383
2077-0383
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9657076
source PMC (PubMed Central); Publicly Available Content (ProQuest)
subjects Clinical trials
Drug abuse
Drug overdose
Drug use
Fatalities
Heroin
Hospitalization
Mental disorders
Mental health
Narcotics
Patients
Pessimism
Post traumatic stress disorder
Respiratory distress syndrome
Substance abuse treatment
Substance use disorder
Suicidal behavior
Suicides & suicide attempts
title Suicidality as a Predictor of Overdose among Patients with Substance Use Disorders
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T06%3A14%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suicidality%20as%20a%20Predictor%20of%20Overdose%20among%20Patients%20with%20Substance%20Use%20Disorders&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Horigian,%20Viviana%20E&rft.date=2022-10-29&rft.volume=11&rft.issue=21&rft.spage=6400&rft.pages=6400-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm11216400&rft_dat=%3Cproquest_pubme%3E2735873555%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-b78d6dbfebd28e8f569a3f06d214270fb00b88cd81134cc00723c3a96c5fba823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2734630815&rft_id=info:pmid/36362628&rfr_iscdi=true